SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
11.65
+0.39 (3.46%)
Oct 9, 2026, 4:00 PM EDT - Market closed
SLS Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
2.35B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.00M | -6.60M | -86.84% |
| Dec 31, 2021 | 7.60M | 5.70M | 300.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Harmony Biosciences Holdings | 959.90M |
| ADMA Biologics | 512.28M |
| Aurinia Pharmaceuticals | 311.51M |
| Beam Therapeutics | 156.04M |
| Recursion Pharmaceuticals | 54.86M |
| Nurix Therapeutics | 36.77M |
| Immunome | 4.02M |
| Celldex Therapeutics | 158.00K |
SLS News
- 3 days ago - Sellas Life Sciences put volume heavy and directionally bearish - TheFly
- 15 days ago - Sellas Life Sciences presents preclinical data on SLS009 at AACR Conference - TheFly
- 15 days ago - SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancreatic Cancer - GlobeNewsWire
- 5 weeks ago - SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer - GlobeNewsWire
- 6 weeks ago - SELLAS Life Sciences Stock (SLS) Has a Major Catalyst on the Horizon - TipRanks
- 7 weeks ago - Moderna data bode well for Sellas into imminent readout, says Maxim - TheFly
- 7 weeks ago - Sellas Life Sciences price target raised to $35 from $25 at Alliance Global - TheFly
- 2 months ago - SELLAS Life Sciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire